-

CIVCO’s Universal Couchtop Validated by Mevion Medical Systems

LITTLETON, Mass.--(BUSINESS WIRE)--CIVCO Radiotherapy and Mevion Medical Systems are pleased to announce that Universal Couchtop™ is now validated and available on MEVION S250™ Series Proton Therapy Systems. The Universal Couchtop allows use of CIVCO’s full line of ProtonSeries™ products, including the ProForm™ head & neck immobilization solution.

The ProForm extension accepts a full range of thermoplastic mask options designed to meet the unique requirements of proton therapy. ProForm also features geometry that allows for direct access to effectively treat CNS patients with a large homogeneous treatment area. Utilizing the Universal Couchtop allows dosimetric consistency with CT SIM, photon and proton treatment compatible models, improving clinic workflow.

“We are thrilled to partner with Mevion Medical Systems to offer CIVCO’s Universal Couchtop to their proton clinics around the world. Proton therapy is one of the most advanced forms of radiotherapy in the fight against cancer and this validation brings one of the most modern and comprehensive couchtop solutions for enabling those advanced treatments,” said John Steffen, CIVCO’s Senior Director of Product Management.

“We are very excited to add CIVCO to the lineup of Mevion’s customizable immobilization and positioning solutions on our open-platform proton therapy systems,” said Ying Xiong, vice president of product management at Mevion Medical Systems.

Mevion and CIVCO will be exhibiting at the National Association for Proton Therapy Annual Meeting (NAPT) Virtual Conference, taking place July 24th and throughout August. Visit https://www.napt2020.com/ to learn more.

About Mevion Medical Systems

Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with a presence in Europe and China. For more information, please visit www.mevion.com.

About CIVCO Radiotherapy

CIVCO Radiotherapy has over 35 years’ experience developing, manufacturing, and providing high-quality, innovative, patient-centric solutions in radiotherapy. These solutions include advanced patient immobilization and positioning hardware and consumables, fiducial markers, couchtops and overlays, software, patient care products and advanced 6DOF robotic patient positioning. Corporate information is available at www.CivcoRT.com.

COPYRIGHT © 2020. CIVCO RADIOTHERAPY IS A REGISTERED TRADEMARK OF CIVCO MEDICAL SOLUTIONS.PROFORM, PROTONSERIES AND UNIVERSAL COUCHTOP ARE TRADEMARKS OF CIVCO. ALL OTHER TRADEMARKS ARE PROPERTY OF THEIR RESPECTIVE OWNERS. ALL PRODUCTS MAY NOT BE LICENSED IN ACCORDANCE WITH CANADIAN LAW. 2020CXXXX REV. A

Contacts

Melanie Benton
Sr. Marketing Project Manager
Mevion Medical Systems
+1.978.540.1551
mbenton@mevion.com

Shelli Locklear
Sr. Marketing Manager
CIVCO Radiotherapy
+1 319-248-6619
Shelli.Locklear@CivcoRT.com

Mevion Medical Systems, Inc.


Release Versions

Contacts

Melanie Benton
Sr. Marketing Project Manager
Mevion Medical Systems
+1.978.540.1551
mbenton@mevion.com

Shelli Locklear
Sr. Marketing Manager
CIVCO Radiotherapy
+1 319-248-6619
Shelli.Locklear@CivcoRT.com

Social Media Profiles
More News From Mevion Medical Systems, Inc.

Carilion Clinic and Mevion Medical Systems Announce Plans to Bring Proton Therapy to Southwest Virginia

ROANOKE, Va. & LITTLETON, Mass.--(BUSINESS WIRE)--Carilion Clinic, a leading integrated health system serving western Virginia, and Mevion Medical Systems, the global leader in compact proton therapy, today announced a partnership to bring advanced proton therapy to the new Carilion Taubman Cancer Center, now under construction in Roanoke. A Regional Milestone in Cancer Care The new Carilion Taubman Cancer Center will transform how cancer care is delivered across Southwest Virginia, bringing to...

Loma Linda University Health, Pioneer of Hospital-Based Proton Therapy, Selects Mevion FIT System to Launch Next Era of Cancer Care

LOMA LINDA, Calif. & LITTLETON, Mass.--(BUSINESS WIRE)--Loma Linda University Health (LLUH), the institution that created the world's first hospital-based Proton Therapy Treatment Center in 1990, and Mevion Medical Systems, the leading provider of compact proton therapy solutions, today announced a historic partnership to install the MEVION S250-FIT Proton Therapy System™. This milestone represents both a clinical leap forward and a symbolic return to the front lines of innovation for LLUH, lau...

Mevion Medical Systems Announces FDA Clearance for MEVION S250-FIT™ Proton Therapy System

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the MEVION S250-FIT™ Proton Beam Radiation Therapy System, marking a significant milestone in expanding access to proton therapy.  The MEVION S250-FIT is the first and only proton therapy system designed to seamlessly fit into a standard radiation therapy vault. By leveraging existing infrastructure, the MEVION S250-FIT system lowers barrier...
Back to Newsroom